WO2006097432A3 - Keratin-biktdende desmoplakinpolypeptidsequenzen - Google Patents

Keratin-biktdende desmoplakinpolypeptidsequenzen Download PDF

Info

Publication number
WO2006097432A3
WO2006097432A3 PCT/EP2006/060607 EP2006060607W WO2006097432A3 WO 2006097432 A3 WO2006097432 A3 WO 2006097432A3 EP 2006060607 W EP2006060607 W EP 2006060607W WO 2006097432 A3 WO2006097432 A3 WO 2006097432A3
Authority
WO
WIPO (PCT)
Prior art keywords
keratin
binding
desmoplakin
domain
polypeptide sequences
Prior art date
Application number
PCT/EP2006/060607
Other languages
English (en)
French (fr)
Other versions
WO2006097432A2 (de
Inventor
Heiko Barg
Thomas Subkowski
Hans-Georg Lemaire
Claus Bollschweiler
Arne Ptock
Original Assignee
Basf Ag
Heiko Barg
Thomas Subkowski
Hans-Georg Lemaire
Claus Bollschweiler
Arne Ptock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Heiko Barg, Thomas Subkowski, Hans-Georg Lemaire, Claus Bollschweiler, Arne Ptock filed Critical Basf Ag
Publication of WO2006097432A2 publication Critical patent/WO2006097432A2/de
Publication of WO2006097432A3 publication Critical patent/WO2006097432A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die vorliegende Erfindung betrifft neue Keratin-bindende Proteinwirkstoffe, ihre Herstellung und Verwendung. Besonders gut geeignete Kera tin-bindende Polypeptide sind solche Sequenzen, die im humanen Desmoplakin enthalten sind oder durch Veränderung der humanen Desmoplakinpolypeptidsequenzen wie Aminosäure-Insertionen, -Substitutionen oder -Deletionen daraus abgeleitet wird. Die Polypeptidsequenz des humanen Desmoplakins ist SEQ ID KO: 1 dargestellt. Eine geeignete Keratin-bindende Domäne (Domäne B) ist die Polypeptidsequenz SEQ ID WO: 1 Position 2193 bis 2481 sowie deren funktionelle Äquivalente. Eine weitere Keratin-bindende Domäne (Domäne C) ist die Polypeptidsequenz SEQ ID NO: 1 Position 2606 bis 2871 sowie deren funktionelle Äquivalente .
PCT/EP2006/060607 2005-03-14 2006-03-09 Keratin-biktdende desmoplakinpolypeptidsequenzen WO2006097432A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200510011988 DE102005011988A1 (de) 2005-03-14 2005-03-14 Die vorliegende Erfindung betrifft die Verwendung von Keratin-bindenden Polypeptiden und ihre Herstellung
DE102005011988.3 2005-03-14

Publications (2)

Publication Number Publication Date
WO2006097432A2 WO2006097432A2 (de) 2006-09-21
WO2006097432A3 true WO2006097432A3 (de) 2007-04-19

Family

ID=36992087

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/060607 WO2006097432A2 (de) 2005-03-14 2006-03-09 Keratin-biktdende desmoplakinpolypeptidsequenzen

Country Status (2)

Country Link
DE (1) DE102005011988A1 (de)
WO (1) WO2006097432A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220405B2 (en) 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
AU2006344932A1 (en) * 2005-11-24 2007-12-27 Basf Se Keratin-binding effector molecules, and method for the production thereof
WO2007060116A2 (de) * 2005-11-24 2007-05-31 Basf Se Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen
FR2932087B1 (fr) * 2008-06-10 2012-10-12 Oreal Utilisation cosmetique de proteines de type desmoplakine pour le traitement de la secheresse cutanee
CN114577678A (zh) * 2022-02-16 2022-06-03 南京中医药大学 一种角蛋白脂质体人工皮肤膜及其在外用制剂及化妆品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055320A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Human pancreas and pancreatic cancer associated gene sequences and polypeptides
WO2003042387A1 (fr) * 2001-11-13 2003-05-22 Keio University Nouvelles proteines associees a la keratine des poils

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055320A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Human pancreas and pancreatic cancer associated gene sequences and polypeptides
WO2003042387A1 (fr) * 2001-11-13 2003-05-22 Keio University Nouvelles proteines associees a la keratine des poils
US20050170366A1 (en) * 2001-11-13 2005-08-04 Jun Kudo Novel hair keratin-associated proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEONG J E LAI ET AL: "Molecular abnormalities of the desmosomal protein desmoplakin in human disease.", CLINICAL AND EXPERIMENTAL DERMATOLOGY. MAY 2005, vol. 30, no. 3, May 2005 (2005-05-01), pages 261 - 266, XP002355355, ISSN: 0307-6938 *
JONKMAN, M.F. ET AL.: "Loss of Desmoplakin Tail Causes Lethal Acantholytic Epidermolysis Bullosa", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 77, no. 4, October 2005 (2005-10-01), pages 653 - 660, XP002407500 *

Also Published As

Publication number Publication date
WO2006097432A2 (de) 2006-09-21
DE102005011988A1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
WO2005115306A3 (de) Keratin-bindende polypeptide
WO2006097432A3 (de) Keratin-biktdende desmoplakinpolypeptidsequenzen
WO2006117565A3 (en) Glucagon-like-peptide-2 (glp-2) analogues
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
EP2476698A3 (de) Peptidvakzinen für MPHOSPH1- oder DEPDC1-Polypeptide exprimierenden Krebs
WO2009004315A8 (en) Isolated peptides and uses thereof
WO2011036445A3 (en) Polypeptides and uses thereof
NZ602170A (en) Modified leptin polypeptides and their uses
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
WO2010126156A3 (en) Alkaline protease variants
WO2009069808A1 (ja) 新規活性を有するEphA4ポリペプチドおよびその用途
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2008113970A3 (en) Peptides
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2006029343A3 (en) Peptides that selectively home to heart vasculature and related conjugates and methods
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
WO2008012689A3 (en) Cytokine derivatives
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen
WO2009118710A3 (en) Cd4-related polypeptides and methods of use
WO2005116189A3 (en) Compositions and use of inflammation-20 (inf-20) gene
WO2007073845A3 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2007005733A3 (en) Novel peptides promoting neurite outgrowth

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06708708

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06708708

Country of ref document: EP

Kind code of ref document: A2